Plurderapolis · Evidence base
Our Sources
Every study, agency page, and reference cited anywhere on this site, gathered in one place and grouped by the page that uses it. Each guide also keeps its own short source list at the bottom of the page. Last reviewed: October 2026.
Homepage
View page- JAMA Psychiatry, October 7, 2026: orphine detections study, the source for the homepage supply alert
Aftercare & Recovery
View pageBad Trip Guide
View pageConsent Culture
View pageDrink Spiking Awareness & Prevention
View pageEmergency Response
View pageIs Your Substance Real? - Harm Reduction & Safety Guide
View page- Zhu et al., JAMA Psychiatry (Oct 7, 2026): orphine detections in 22 states; Minnesota detections were brorphine
- CDC Health Alert Network HAN 00527: Medetomidine in the U.S. Illegal Fentanyl Supply (April 2, 2026)
- CDC: Fentanyl testing guidance
- CDC: What you should know about xylazine
- SAMHSA Overdose Prevention and Response Toolkit (2025)
- Minnesota Dept. of Health: Overdose prevention
- DEA: Facts about fentanyl
- Minn. Stat. 604A.05 (Good Samaritan overdose medical assistance)
- DanceSafe: testing resources
Mental Health & the Scene
View pageNight Out Checklist Builder
View pageOverdose: Recognize & Respond
View pagePanic Help
View pagePolydrug Risks
View pagePolydrug Risks & Interaction Checker
View pagePsychedelics Guide
View page- DEA: Hallucinogens fact sheet: effects, physiological risks, and overdose profiles
- StatPearls: Serotonin Syndrome (NCBI Bookshelf): signs, severity, and interacting drug classes
- Nayak et al., Pharmacopsychiatry (2021): lithium plus classic psychedelics and seizure risk
- Orsolini et al. (2017), peer reviewed review of HPPD: persisting visual disturbances, course, and triggers
- Paris et al., Practical Neurology (2023): nitrous oxide related spinal damage: B12 inactivation and nerve injury
- Mishkan Collective: 2C-B info card (PDF), a community harm reduction card, not a clinical source: duration, effects, and the tusi distinction, as described by the community card
- Erowid: LSD health and cautions: tolerance, HPPD, lithium and SSRI interactions
- Minnesota Statutes 152.02: controlled substance scheduling
- Minnesota Revisor: HF 2906, psilocybin therapy bill: the 2025-26 session ended with no program enacted; lawmakers directed only an Office of Cannabis Management feasibility study, due January 15, 2027
- DanceSafe: harm reduction and drug checking resources
- CDC and FDA: Diamond Shruumz outbreak investigation (2024): 180 illnesses in 34 states; FDA testing found undisclosed substances including psilocin and O-acetylpsilocin, and no psilocybin
Raver Survival Guide
View pageRejection Based Violence
View pageRide Safety & Bystander Basics: Complete Guide
View pageRX + Party Drug Combos
View pageSafer Snorting & Route Safety
View pageSobredosis: Reconoce y Actúa
View pageStart Here
View pageTest Strips: Check Before You Use
View pagePlurderapolis is a harm reduction reference based on established harm reduction resources and clinical literature. This site is for education only and is not medical or legal advice. In any emergency, call 911. Minnesota's Good Samaritan law, Minn. Stat. 604A.05, protects people who call for help.